Concord Wealth Partners’s Halozyme HALO Stock Holding History

Concord Wealth Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.29K	Hold	66	–	–	﹤0.01%	589
2026 Q2	$5.17K	Buy	+66	New	+$4.5K	﹤0.01%	656
2026 Q1	–	Sell	-66	Closed	-$4.44K	–	442
2025 Q4	$4.44K	Hold	66	–	–	﹤0.01%	639
2025 Q3	$4.84K	Hold	66	–	–	﹤0.01%	628
2025 Q2	$3.43K	Hold	66	–	–	﹤0.01%	677
2025 Q1	$4.21K	Hold	66	–	–	﹤0.01%	606
2024 Q4	$3.16K	Hold	66	–	–	﹤0.01%	658
2024 Q3	$3.78K	Hold	66	–	–	﹤0.01%	674
2024 Q2	$3.46K	Hold	66	–	–	﹤0.01%	617
2024 Q1	$2.68K	Hold	66	–	–	﹤0.01%	721
2023 Q4	$2.44K	Hold	66	–	–	﹤0.01%	695
2023 Q3	$2.52K	Hold	66	–	–	﹤0.01%	837
2023 Q2	$2.38K	Hold	66	–	–	﹤0.01%	837
2023 Q1	$2.52K	Hold	66	–	–	﹤0.01%	778
2022 Q4	$3.76K	Buy	+66	New	+$3.38K	﹤0.01%	821
2022 Q3	–	Sell	-66	Closed	-$3K	–	559
2022 Q2	$3K	Hold	66	–	–	﹤0.01%	942
2022 Q1	$3K	Hold	66	–	–	﹤0.01%	1016
2021 Q4	$3K	Hold	66	–	–	﹤0.01%	1055
2021 Q3	$3K	Hold	66	–	–	﹤0.01%	686
2021 Q2	$3K	Hold	66	–	–	﹤0.01%	816
2021 Q1	$3K	Hold	66	–	–	﹤0.01%	756
2020 Q4	$3K	Buy	+66	New	+$2.37K	﹤0.01%	470

Other funds holding HALO

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Concord Wealth Partners's HALO Position: Q3 2026 in Review

Concord Wealth Partners held its Halozyme (HALO) position steady in Q3 2026 at 66 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

Concord Wealth Partners first reported a position in HALO in Q4 2020 and has held it in 22 quarters since. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

Concord Wealth Partners held 66 shares of Halozyme worth $7.29K as of Q3 2026.
Concord Wealth Partners left its Halozyme share count unchanged in Q3 2026.
Halozyme made up ﹤0.01% of Concord Wealth Partners's portfolio in Q3 2026, its #589 holding.
Concord Wealth Partners first reported a position in Halozyme in Q4 2020 and has held it in 22 quarters since.
636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Concord Wealth Partners's 13F filing for Q3 2026, filed 2 Nov 2026.